Pemphigus Herpetiformis in Childhood: Clinical Case

Background. Pemphigus herpetiformis is a rare atypical bullous dermatosis of autoimmune nature. It is characterized by rashes in the form of plaques with papules and vesicles at peripheral areas, or in the form of grouped papules, vesicles or tense bubbles with clinical similarity to During's herpetiformis dermatitis. Pemphigus herpetiformis diagnosis in pediatric practice is difficult due to the similarity of clinical manifestations to bullous dermatoses of other etiology, the rarity of the disease in children, and small number of scientific publications.

Clinical case description. Clinical case of pemphigus herpetiformis in a child is described. All necessary diagnostic algorithms for diagnosis and therapeutic tactics for patient management are presented. Dapsone and prednisolone were used as first-line drugs during the patient's treatment. They have shown its efficacy in management of such patients.

Conclusion. Differential diagnosis of pemphigus herpetiformis and other bullous dermatoses in children is presented. The results of successful drug treatment are shown.

1. Puzyrchatka: Clinical recommendations. Russian Society of Dermatovenerologists and Cosmetologists. 2019. (In Russ).

2. Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol. 1975;14(5):353–359. doi: https://doi.org/10.1111/j.1365-4362.1975.tb00125.x

3. Costa Lorena MC, Cappel MA, Keeling JH. Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria. Int J Dermatol. 2019;58(9):997–1007. doi: https://doi.org/10.1111/ijd.14395

4. Floden C, Gentale H. A case of clinically typical dermatitis herpetiformis presenting acantholysis. Acta Derm Venereol. 1955;35(2):128.

5. Abramova TV. Puzyrchatka: immunopatogenez, diagnostika i patogeneticheskaya terapiya (kliniko-eksperimental’noe issledovanie). [abstract of dissertation]. Moscow; 2019. 48 p. (In Russ).

6. Peterman CM, Vadeboncoeur S, Schmidt BA, Gellis SE. Pediatric Pemphigus Herpetiformis: Case Report and Review of the Literature. Pediatr Dermatol. 2017;34(3):342–346. doi: https://doi.org/10.1111/pde.13152

7. Klebes M, Wutte N, Aberer E. Dapsone as second-line treatment for cutaneous lupus erythematosus. A retrospective analysis of 34 patients and a review of the literature. Dermatology. 2016;232(1):91–96. doi: https://doi.org/10.1159/000441054

8. Russo I, Ferrazzi A, Zanetti I, Alaibac M. Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn’s disease. BMJ Case Rep. 2015;2015:bcr2015210210. doi: https://doi.org/10.1136/bcr-2015–210210

9. Kozhnye i venerologicheskie bolezni: Textbook. Olisova OYu, ed. 2nd ed., add. Moscow: Prakticheskaya meditsina; 2019. 296 p. (In Russ).

10. Samtsov AV, Belousova IE. Bulleznye dermatozy: Monograph. St. Petersburg: Kosta; 2012. 144 p. (In Russ).

11. Robinson N, Hashimoto T, Amagai M, et al. The new pemphigus variants. J Am Acad Dermatol. 1999;40(5 Pt 1):649–671; quiz 672–673. doi: https://doi.org/10.1016/s0190-9622(99)70145-3

12. Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis. 1895;13:10.

13. Matushevskaya EV, Svirshchevskaya EV, Kubanova AA, et al. Pemphigus vulgaris: immunological aspects and possible mechanism of the disease development. Vestnik Dermatologii i Venerologii. 1996;(2):25–28. (In Russ).

14. Grandо SA. Pemphigus autоimmunity: hypоtheses and realities. Autоimmunity. 2012;45(1):7–35. doi: https://doi.org/10.3109/08916934.2011.606444

15. Wojnarowska F, Venning V. Immunobullous Diseases. In: Rook’s Textbook of Dermatology. Burns T, Breathnach S, Cox N, Griffiths C, eds. 8th ed. Wiley-Blackwell; 2010. Ch. 40. doi: https://doi.org/10.1002/9781444317633.ch40

16. Santi S, Maruta C, Aoki V, et al. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. J Am Acad Dermatol. 1996;34(1):40–46. doi: https://doi.org/10.1016/s01909622(96)90832-4

17. Megahed M. Histopathology of Blistering Diseases. Springer; 2004. pp. 174–122.

18. Mutasim D. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol. 2004:51(6); 859–877. doi: https://doi.org/10.1016/j.jaad.2004.02.013